Sanofi-Aventis, Merrimack Enter Into Global Collaboration, Licensing Agreement
Published: 01-Oct-2009
Sanofi receives license to develop, manufacture and commercialise MM-121
Sanofi-Aventis and Merrimack Pharmaceuticals have announced a global collaboration and licensing agreement on MM-121, a first-in-class, fully human monoclonal antibody designed to block signaling of the ErbB3 (HER3) receptor, for the management of solid malignancies. MM-121 is currently in phase 1 clinical testing.
Under the agreement, Sanofi-Aventis will receive worldwide license to develop, manufacture and commercialise MM-121. Merrimack will retain potential co-promotion rights in the US.
Marc Cluzel, senior vice president of R&D at Sanofi-Aventis, said: “Merrimack’s expertise along with their knowledge of biologics development has allowed them to successfully identify ErbB3 as a promising target and rapidly bring MM-121 into clinical development. MM-121 is a pioneering monoclonal antibody which brings a new innovative approach to Sanofi-Aventis’ oncology portfolio. We are very excited to collaborate with Merrimack on the development of MM-121, which we believe is a very promising compound that will address a significant gap in treating cancer patients.”
Under the terms of the agreement, Sanofi-Aventis agreed to pay Merrimack an upfront cash payment of $60m for the research, development, manufacturing and commercialisation rights. Merrimack is eligible for development and regulatory milestone payments up to $410m on MM-121, royalties on the
worldwide product sales and will receive additional performance milestones of up to $60m. Merrimack will participate in the development of MM-121.
Delicious
Digg
Reddit
Stumble
Facebook
LinkedInNetwork Sites
Mail sent successfully
Suppliers To This Sector
Browse A-Z
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Turku Region
A Bright Future in a Great Location ...
TNO
Pharma Services: From Discovery to the Clinic ...
Thomson Reuters
The World's Leading Source of Life Sciences Intelligent Information ...
Thermo Fisher Scientific
The world leader in serving science ...
Tecnosoft
Monitoring Systems for Temperature, Humidity and Pressure ...
White Papers
Browse A-Z
Your IP at Risk in Collaborations!
Free white paper: Ten steps to protect your R&D investment within partnerships. ...
Why, When and How to Conduct 14C Human Studies
Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...
Why CAPA Still Matters
This free white paper explores the needs and effectiveness of correct CAPA control, how to ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly
Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...
USB HotStart-IT for Real Time PCR
USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...
